Compare Range Nuclear Renaissance ETF (NUKZ) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Range Nuclear Renaissance ETF vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Range Nuclear Renaissance ETF trades at $61.06 (market cap $698.21M), while Nuvation Bio Inc. Class A Common Stock trades at $5.07 (market cap $1.74B). The key difference: Nuvation Bio Inc. Class A Common Stock is far larger — about 2.5× Range Nuclear Renaissance ETF's market cap, and Nuvation Bio Inc. Class A Common Stock is trading nearer its 52-week high, Range Nuclear Renaissance ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Range Nuclear Renaissance ETF for 18 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.
| NUKZ | NUVB | |
|---|---|---|
Market Cap | $698.21M | $1.74B |
Volume | 57,444 | 9,289,619 |
Sector | Sector/Thematic | Health |
52-Week High | $76.23 | $9.54 |
52-Week Low | $60.23 | $3.41 |
Typical Hold Time | 18 Days | 1 Days |
Enterprise Value | — | $1.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Range Nuclear Renaissance ETF
Range Nuclear Renaissance ETF seeks to track companies related to the nuclear energy industry. Its holdings may include businesses involved in uranium, nuclear power generation, reactors, and nuclear services.
Read more on NUKZ →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
